Eicosapentaenoic Acid as a Potential Therapeutic Approach to Reduce Cardiovascular Risk in Patients with End-Stage Renal Disease on Hemodialysis: A Review.
| Author | |
|---|---|
| Abstract | :
Patients with end-stage renal disease on hemodialysis have excess cardiovascular disease (CVD) burden with substantially increased CV event rates compared with the general population. |
| Year of Publication | :
2017
|
| Journal | :
Cardiorenal medicine
|
| Volume | :
8
|
| Issue | :
1
|
| Number of Pages | :
18-30
|
| ISSN Number | :
1664-3828
|
| DOI | :
10.1159/000479391
|
| Short Title | :
Cardiorenal Med
|
| Download citation |